Fundraising Fox

mpathic

Founded 2021 Β· 125 employees on LinkedIn Β· 11 known investors

Mpathic provides red-teaming and model safety evaluation services for conversational AI systems, using a curated network of over 5,000 licensed U.S.-based clinical experts including psychologists, psychiatrists, and social workers to surface harms, test for bias and misinformation, and design evaluation frameworks.

Also known as Empathy Rocks, Inc. Β· mpathic AI Β· mpathic.ai

Founders & leadership

mpathic was founded in 2021 by Grin Lord.

GLGrin Lord
Grin LordinFounder - CEO

Investors Β· 11

Also in the syndicate Β· 3

Full-CircleGraham & WalkerIlluminate

Company profile

researched Aug 2026

mpathic is a clinician-founded AI safety company that helps AI developers evaluate, stress-test and improve human-facing models using behavioral science methods. Its services center on expert-led red teaming to surface failure modes, misalignment, bias and risks that automated tests and synthetic-data evaluations miss, and on ground-truth benchmarking that measures model performance on nuanced, high-stakes human behaviors. The company emphasizes detection of responses that pose physical or psychological risk to vulnerable populations before deployment, and translates evaluation results into insights that inform training data curation and fine-tuning. An optional product, mpathic Studio, supports AI-assisted annotation, benchmarking and reinforcement learning on models and multi-modal data.

The company works with a large pool of mental health experts, doctors, clinicians and other safety specialists, alongside actors, writers and red-teamers who build reinforcement learning and evaluation environments. Its benchmarking methodology compares model predictions to gold-standard human judgments: coders establish interrater reliability before creating ground-truth datasets, and models are scored on absolute agreement, precision, recall and F1 across domains including motivational interviewing, empathy and soft skills in medical settings, clinical risk and misconduct, and patient adherence. Published research themes include the mPACT benchmark family (a suicide benchmark, mPACT-S-v1.0, and an eating disorders benchmark, mPACT-ED-v1.0), fidelity and skill evaluation in clinical settings, safety and cultural responsiveness, LLM summarization for counseling, and multimodal applications such as robotic surgery communication and speaker attribution in clinical conversations.

Earlier descriptions of the company characterized it as enterprise software analyzing conversations across text, email and audio to flag potential misunderstandings and enable real-time adjustment β€” described by its CEO as "Grammarly for empathy" β€” with proprietary machine learning models identifying more than 100 conversational behaviors, and applications in clinical trial fidelity monitoring, adverse-event review and FDA adherence in CNS trials.

Founding story

Founder and CEO Dr. Grin Lord is a psychologist-researcher who spent roughly 15 years studying the elements of conversation that build trust and empathy, working as a clinician-researcher at the University of Washington's Department of Psychiatry and Behavioral Sciences from 2007, and later serving as Chief Clinical Officer at Lyssn.io and Clinical Product Psychologist at Youper.ai. She has said she started mpathic to make empathy β€” which she defines as accurate understanding β€” accessible to anyone through AI-driven coaching and correction, and the mission expanded into life-science applications such as detecting patient side effects or suicidal ideation in clinical conversations. Before mpathic, Lord and company architect Nic Bertagnolli started Empathy Rocks, a gamified platform using empathic AI.

Business model

mpathic sells expert-led evaluation services and software to organizations building human-facing AI. Engagements include red teaming, benchmarking against expert-rated ground truth, and delivery of model-ready insights for training-data curation and fine-tuning; customers can optionally use mpathic Studio for AI-assisted annotation, reinforcement learning and benchmarking. Earlier positioning described an enterprise conversation analytics and coaching platform plus an API for developers building emotion-AI applications, applied to clinical trial fidelity monitoring and medical monitor augmentation.

Revenue derives from paid engagements with AI builders for red teaming, benchmarking and evaluation, and from use of the mpathic Studio annotation and benchmarking product; earlier, from enterprise conversation analytics software and an API for emotion-AI applications.

Traction

As of June 2022 the company had 12 employees and had raised $5.2 million in total. It reports working with thousands of mental health experts, doctors, clinicians and other safety experts, and cites a customer in clinical trials that previously spent eight hours a day reviewing videos for adverse events. Public endorsements come from academic clinicians at Stanford, UC Berkeley and Washington University School of Medicine, and a clinical lead for mental health evaluation at a Fortune 100 AI lab is quoted as a client.

Latest developments

mpathic has published the mPACT benchmark family, including mPACT-S-v1.0 for suicide-related model behavior and mPACT-ED-v1.0 for eating disorders, and promotes expert-led red teaming and ground-truth benchmarking services alongside mpathic Studio for AI-assisted annotation and reinforcement learning. The executive team includes CEO and founder Dr. Grin Lord, co-founder and Chief Business Officer Dr. Danielle Schlosser, Chief Science Officer Dr. Alison Cerezo, COO and Chief Legal Officer Megan Fouty, CMO Rebekah Bastian, VP of Product Success Dr. Amber Jolley-Paige, and Chief Technology and Information Security Officer Brian Williams.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history

Market position

mpathic describes itself as a clinician-founded AI safety company backed by venture investors, and states it has a highly specialized pool of safety experts for red teaming and benchmarking. It competes for evaluation work in domains such as youth-facing AI, medical settings and mental health, where it argues comprehensive, evidence-based and clinically grounded evaluation frameworks are still lacking.

mpathic positions its work around human clinical expertise embedded throughout the evaluation process β€” from scenario design to rating β€” rather than relying solely on automated or LLM-based judgment. It cites peer-reviewed validation, established coding systems, interrater-reliability procedures and gold-standard human comparison sets, and access to a large specialized pool of mental health and safety experts as the basis for its benchmarks. Third-party academics quoted by the company note the clinical grounding and real-world stress-testing approach of the mPACT framework.

Technology

mpathic combines expert human judgment with machine learning models that detect and evaluate human risk in conversational and multi-modal data. Proprietary ML models identify, correct and enhance over 100 conversational behaviors; models are benchmarked against human expert raters using established coding systems and safety frameworks, with performance measured by absolute agreement, precision, recall and F1. The mpathic Studio product supports AI-assisted annotation, reinforcement learning and benchmarking. A patent-style publication covers a system and method for improving communication through evaluation of multimodal data, auto-correction and behavioral suggestions based on evidence-based counseling, motivational interviewing and empathy models.

Go-to-market

mpathic markets directly to AI builders and labs through demo requests and consultative engagements, supported by published research and benchmark releases, academic endorsements, and recruitment of clinical and safety experts into its evaluation network. Earlier go-to-market included an API for developers of emotion-AI applications and enterprise sales into healthcare, life sciences and client services.

AI builders and labs deploying human-facing models in high-stakes domains, including products for children, medical settings and mental health; earlier customers included healthcare, life sciences and client-services organizations, with use cases spanning customer service, insurance claims, HR software and clinical trial monitoring.

Geography

The company is based in the Seattle area, with an address listed at 14655 Bel-Red Road, Suite 203, Bellevue, Washington, United States.

History

The company was founded in 2021 by psychologist Grin Lord, who had previously worked with mpathic architect Nic Bertagnolli on Empathy Rocks, a gamified empathic-AI platform; the corporate entity Empathy Rocks, Inc. does business as mpathic. In June 2022 the company announced a $4 million seed round, reporting 12 employees and $5.2 million raised to date. By 2023 mpathic was positioned as a conversation analytics and coaching platform for healthcare, life sciences and client services, with use cases in clinical trial fidelity monitoring and FDA adherence for CNS trials. More recently the company has focused on AI safety work for AI builders, including expert-led red teaming and the mPACT clinical benchmark suite.

Compiled by commissioned research from 8 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
Conversational behaviors identified by modelsJan 2023over 100 behaviors observed in conversations
EmployeesJun 202212 people
HeadcountAug 2026125
Total funding raisedJun 2022$5.2M

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Competitors Β· 2

by search overlap

Companies competing with mpathic for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline Β· 2

launches, deals, and filings
Jan 2026
mPACT clinical benchmark suite for LLMs

mpathic describes mPACT (mpathic Psychologist-led AI Clinical Tests), including a suicide benchmark (mPACT-S-v1.0, Cerezo et al., 2026) and an eating disorders benchmark (mPACT-ED-v1.0, Douglas et al., 2026), in which expert clinicians interact with LLMs and simulate patients to stress-test model responses.

source β†—

Jun 2022
mpathic announces $4M seed round led by Next Frontier Capital

GeekWire reported mpathic raised a $4 million seed round led by Next Frontier Capital, bringing total capital raised to $5.2 million.

$4M source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

β–ΈResearch sources Β· 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does mpathic do?
Clinician-founded AI safety company providing expert-led red teaming and clinically grounded benchmarking for human-facing AI models.
Who founded mpathic?
mpathic was founded by Grin Lord in 2021.
Who are mpathic's investors?
mpathic's investors include First Row Partners, Graham Walker Venture, Next Frontier Capital, Portland Seed Fund, Verissimo Ventures, WXR Fund, FullCircle, Illuminate Ventures.